Comparison of interleukin-6 levels in maternal and umbilical cord blood in early- and late-onset preeclampsia

Gynecological Endocrinology

Volumn 28, Issue 8, 2012, Pages 640-643

  Küçük, Mert ^a   Sezer, Selda Demircan ^a   Yenisey, Çiǧdem ^a   Yüksel, Hasan ^a   Odabaşi, Ali Riza ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

Early onset preeclampsia; IL 6; late onset preeclampsia; umbilical cord

Indexed keywords

INTERLEUKIN 6; IL6 PROTEIN, HUMAN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MATERNAL BLOOD; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; UMBILICAL CORD BLOOD; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS BLOOD; IMMUNOLOGY; PATHOPHYSIOLOGY; PREGNANCY; PROSPECTIVE STUDY; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; THIRD TRIMESTER PREGNANCY; TURKEY (REPUBLIC);

ADULT; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FETAL BLOOD; HUMANS; INTERLEUKIN-6; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY TRIMESTER, THIRD; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TURKEY; YOUNG ADULT;

EID: 84863862641     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2011.650771     Document Type: Article

References (23)

1. Stein K, Ascher-Walsh C. A comprehensive approach to the treatment of uterine leiomyomata. Mt Sinai J Med 2009;76:546-556.
2. Hensley ML, Ishill N, Soslow R, Larkin J, Abu-Rustum N, Sabbatini P, Konner J, et al. Adjuvant gemcitabine plus docetaxel for completely resected stages I-IV high grade uterine leiomyosarcoma: results of a prospective study. Gynecol Oncol 2009;112:563-567.
3. Chen L, Yang B. Immunohistochemical analysis of p16, p53, and Ki-67 expression in uterine smooth muscle tumors. Int J Gynecol Pathol 2008;27:326-332.
4. Morrison DK. The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol 2009;19:16-23.
5. Tzivion G, Gupta VS, Kaplun L, Balan V. 14-3-3 proteins as potential oncogenes. Semin Cancer Biol 2006;16:203-213.
6. Hermeking H, Benzinger A. 14-3-3 proteins in cell cycle regulation. Semin Cancer Biol 2006;16:183-192.
7. Yoshida S, Ohara N, Xu Q, Chen W, Wang J, Nakabayashi K, Sasaki H, et al. Cell-type specific actions of progesterone receptor modulators in the regulation of uterine leiomyoma growth. Semin Reprod Med 2010;28:260-273.
8. Blake RE. Leiomyomata uteri: hormonal and molecular determinants of growth. J Natl Med Assoc 2007;99:1170-1184.
9. Ohara N. Selective estrogen receptor modulator and selective progesterone receptor modulator: therapeutic efficacy in the treatment of uterine leiomyoma. Clin Exp Obstet Gynecol 2005;32:9-11.
10. Chwalisz K, Perez MC, Demanno D, Winkel C, Schubert G, Elger W. Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis. Endocr Rev 2005;26:423-438.
11. Chabbert-Buffet N, Meduri G, Bouchard P, Spitz IM. Selective progesterone receptor modulators and progesterone antagonists: mechanisms of action and clinical applications. Hum Reprod Update 2005;11:293-307.
12. Mhawech P. 14-3-3 proteins-an update. Cell Res 2005;15:228-236.
13. Martinez JD. 14-3-3 proteins: do they have a role in human cancer? Future Oncol 2005;1:631-633.
14. Wilker E, Yaffe MB. 14-3-3 Proteins-a focus on cancer and human disease. J Mol Cell Cardiol 2004;37:633-642.
15. Moreira JM, Gromov P, Celis JE. Expression of the tumor suppressor protein 14-3-3 σ is down-regulated in invasive transitional cell carcinomas of the urinary bladder undergoing epithelial-tomesenchymal transition. Mol Cell Proteomics 2004;3:410-419.
16. Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, et al. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma. Oncogene 2000;19:5298-5302.
17. Suzuki H, Itoh F, Toyota M, Kikuchi T, Kakiuchi H, Imai K. Inactivation of the 14-3-3 σ gene is associated with 5' CpG island hypermethylation in human cancers. Cancer Res 2000;60:4353-4357.
18. Villaret DB, Wang T, Dillon D, Xu J, Sivam D, Cheever MA, Reed SG. Identification of genes overexpressed in head and neck squamous cell carcinoma using a combination of complementary DNA subtraction and microarray analysis. Laryngoscope 2000;110:374-381.
19. Gasco M, Sullivan A, Repellin C, Brooks L, Farrell PJ, Tidy JA, Dunne B, et al. Coincident inactivation of 14-3-3σ and p16INK4a is an early event in vulval squamous neoplasia. Oncogene 2002;21:1876-1881.
20. Maruo T, Ohara N, Wang J, Matsuo H. Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update 2004;10:207-220.
21. Ishikawa H, Ishi K, Serna VA, Kakazu R, Bulun SE, Kurita T. Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology 2010;151:2433-2442.
22. Wango EO, Tabifor HN, Muchiri LW, Sekadde-Kigondu C, Makawiti DW. Progesterone, estradiol and their receptors in leiomyomata and the adjacent normal myometria of black Kenyan women. Afr J Health Sci 2002;9:123-128.
23. Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 2003;111:1037-1054.